Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Holders of 5% or more of ALBO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Albireo Pharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Albireo Pharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Albireo Pharma, Inc., newest first.
No Schedule 13D or 13G filings on Albireo Pharma, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Albireo Pharma, Inc. shares.
No Form 144 notices for Albireo Pharma, Inc. are on file.